The at-home kits were divvied up and picked up by 19 different school districts in Erie County for distribution.

Based on sequence analysis and Omicron recombinant protein test, Omicron variant does not have influence on the target region of  CareStart™ COVID-19 Rapid and PCR Tests. 

In accordance with Article 16 (1) of the “Korean Depository Receipt Agreement” signed between Access Bio and Korea Securities Depository on March 11, 2013, the Record Date for determining shareholders in 2020 is December 31, 2020.

Major supply chain agreements will ensure broad access to rapid testing solutions for patients and healthcare providers across US

Global Leader in Infectious Disease Diagnosis Receives FDA EUA for Serology Test Capable of Determining Subjects’ past COVID-19 Exposure and Immunoresponse within 10 Minutes

Access Bio was founded on the basic principle of cherishing life and health for all people. The company has emerged as a leader in the diagnosis of infectious diseases. Although it provides a comprehensive portfolio, Access Bio is known for its work against malaria, HIV, HPV, and now, COVID-19.

New rapid diagnostic test now available to research organizations for low parasitemia settings